Immunobridging for Pemivibart, a Monoclonal Antibody for Prevention of Covid-19

Pemivibart, a monoclonal antibody for preexposure prophylaxis for SARS-CoV-2, was recently authorized for emergency use by the FDA. The immunobridging data on which this EUA is based are presented.

​   The New England Journal of Medicine: Search Results in Allergy/Immunology